OVARIAN CANCER and US

An ovarian cancer blog which includes quality resource materials: education, research, social networking, genetics and (some) healthcare politics.

“Not everything that can be counted counts and not everything that counts can be counted.”
Albert Einstein

Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label Picoplatin. Show all posts
Showing posts with label Picoplatin. Show all posts
Wednesday, March 24, 2010

financial news - Picoplatin - UPDATE 3-Poniard suspends regulatory efforts on key drug | Reuters

›
Note : read the whole article "The company said it would focus its resources on developing clinical strategies for picoplatin in sma...
Monday, January 25, 2010

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors - Full Text View - ClinicalTrials.gov

›
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors - Full Text View - ClinicalTrials.gov: " T...

Pharma press release: re Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives

›
"Our ultimate goal is to secure a strategic partnership to support further development of picoplatin in CRC and other solid tumor indic...
›
Home
View web version

Sandi Pniauskas Ovarian Cancer and Us

OvarianCancerandUs
View my complete profile
Powered by Blogger.